LON:AREC

Arecor Therapeutics (AREC) Share Price, News & Analysis

Arecor Therapeutics logo
GBX 72 -4.00 (-5.26%)
As of 11/20/2026 09:56 AM Eastern

About Arecor Therapeutics Stock (LON:AREC)

Advanced

Key Stats

Today's Range
72
▼
76.38
50-Day Range
70.31
▼
90
52-Week Range
56
▼
95
Volume
8,434 shs
Average Volume
25,830 shs
Market Capitalization
£32.62 million
P/E Ratio
72.00
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Arecor Therapeutics plc (AIM: AREC) is a clinical-stage biotech company developing superior therapeutics that can reduce treatment burden and improve outcomes for people living with diabetes, obesity and other cardiometabolic diseases. Lead product, AT278, is the only ultra-concentrated (500U/mL) ultra-rapid-acting insulin in development. Arecor has signed an initial strategic partnership with Sequel Med Tech, a leading automated insulin delivery (AID) system company to co-develop AT278 in combination with Sequel’s twiist™ AID system. Clinically de-risked, AT278 is designed to transform AID systems, addressing a multi-billion-dollar diabetes market. Arecor is also developing a novel oral delivery platform for peptides with GLP-1 receptor agonists its first validation target.

Receive AREC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AREC Stock News Headlines

Arecor Therapeutics PLC
CFA: Bank of America Said THIS
On January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.tc pixel
Patents for concentrated ultra-rapid insulins
Arecor Therapeutics adds patents as it eyes $3 billion US market
Arecor Therapeutics closes oversubscribed retail offer
See More Headlines

AREC Stock Analysis - Frequently Asked Questions

Arecor Therapeutics' stock was trading at GBX 84.45 on January 1st, 2026. Since then, AREC shares have decreased by 14.7% and is now trading at GBX 72.

Arecor Therapeutics plc (LON:AREC) issued its quarterly earnings results on Thursday, October, 1st. The company reported GBX (8) earnings per share (EPS) for the quarter. Arecor Therapeutics had a positive trailing twelve-month return on equity of 3.75% and a negative net margin of 200.00%.

Shares of AREC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Company Calendar

Last Earnings
10/01/2026
Today
11/22/2026

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Energy
Industry
Oil, Gas & Consumable Fuels
Sub-Industry
Coal & Consumable Fuels
Current Symbol
LON:AREC
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 1
Trailing P/E Ratio
72.00
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£10.68 million
Net Margins
-200.00%
Pretax Margin
N/A
Return on Equity
3.75%
Return on Assets
-37.31%

Debt

Debt-to-Equity Ratio
1.55
Current Ratio
4.29
Quick Ratio
6.24

Sales & Book Value

Annual Sales
£890 thousand
Price / Sales
36.65
Cash Flow
GBX 14.20 per share
Price / Cash Flow
5.07
Book Value
GBX 16.58 per share
Price / Book
4.34

Miscellaneous

Outstanding Shares
45,301,000
Free Float
N/A
Market Cap
£32.62 million
Optionable
Not Optionable
Beta
-0.18
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (LON:AREC) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners